{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:12:08Z","timestamp":1720138328464},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00347-024-02061-1","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:01:57Z","timestamp":1718967717000},"page":"540-547","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myasthenie als Ursache einer Vertikaldiplopie im Senium","Myasthenia as the cause of vertical diplopia in the elderly"],"prefix":"10.1007","volume":"121","author":[{"given":"Christina B.","family":"Schroeter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schroeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"2061_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mus.20950","volume":"37","author":"D Grob","year":"2008","unstructured":"Grob\u00a0D, Brunner\u00a0N, Namba\u00a0T, Pagala\u00a0M (2008) Lifetime course of myasthenia gravis. Muscle Nerve 37:141\u2013149","journal-title":"Muscle Nerve"},{"key":"2061_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/ana.410140504","volume":"14","author":"CT Bever","year":"1983","unstructured":"Bever\u00a0CT, Aquino\u00a0AV, Penn\u00a0AS, Lovelace\u00a0RE, Rowland\u00a0LP (1983) Prognosis of ocular myasthenia. Ann Neurol 14:516\u2013519","journal-title":"Ann Neurol"},{"key":"2061_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1749-6632.1987.tb51317.x","volume":"505","author":"D Grob","year":"1987","unstructured":"Grob\u00a0D, Arsura\u00a0EL, Brunner\u00a0NG, Namba\u00a0T (1987) The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci 505:472\u2013499","journal-title":"Ann N Y Acad Sci"},{"key":"2061_CR4","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/ene.12057","volume":"20","author":"H Zach","year":"2013","unstructured":"Zach\u00a0H, Cetin\u00a0H, Hilger\u00a0E et\u00a0al (2013) The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis. Eur J Neurol 20:708\u2013713","journal-title":"Eur J Neurol"},{"key":"2061_CR5","volume-title":"Diagnostik und Therapie myasthener Syndrome, S2k-Leitlinie","author":"H Wiendl","year":"2023","unstructured":"Wiendl\u00a0H, Meisel\u00a0A (2023) Diagnostik und Therapie myasthener Syndrome, S2k-Leitlinie. Deutsche Gesellschaft f\u00fcr Neurologie"},{"key":"2061_CR6","volume-title":"Beschluss des Gemeinsamen Bundesausschusses \u00fcber die Einleitung eines Stellungnahmeverfahrens zur \u00c4nderung der Arzneimittel-Richtlinie (AM-RL): Anlage\u00a0VI \u2013 Off-Label-Use Mycophenolat Mofetil bei Myasthenia gravis","author":"Gemeinsamer Bundesausschuss","year":"2013","unstructured":"Gemeinsamer Bundesausschuss (2013) Beschluss des Gemeinsamen Bundesausschusses \u00fcber die Einleitung eines Stellungnahmeverfahrens zur \u00c4nderung der Arzneimittel-Richtlinie (AM-RL): Anlage\u00a0VI \u2013 Off-Label-Use Mycophenolat Mofetil bei Myasthenia gravis"},{"key":"2061_CR7","doi-asserted-by":"publisher","first-page":"e1617","DOI":"10.1212\/WNL.0000000000010574","volume":"95","author":"M Mendoza","year":"2020","unstructured":"Mendoza\u00a0M, Tran\u00a0C, Bril\u00a0V, Katzberg\u00a0HD, Barnett\u00a0C (2020) Patient-acceptable symptom states in myasthenia gravis. Neurology 95:e1617\u201328","journal-title":"Neurology"},{"key":"2061_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","volume":"19","author":"C Nelke","year":"2022","unstructured":"Nelke\u00a0C, Stascheit\u00a0F, Eckert\u00a0C et\u00a0al (2022) Independent risk factors for myasthenic crisis and disease exacerbation in a\u00a0retrospective cohort of myasthenia gravis patients. J\u00a0Neuroinflammation 19:89","journal-title":"J Neuroinflammation"},{"key":"2061_CR9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/a-0599-0811","volume":"86","author":"HR Stetefeld","year":"2018","unstructured":"Stetefeld\u00a0HR, Schroeter\u00a0M (2018) Myasthenic Crisis. Fortschr Neurol Psychiatr 86:301\u2013307","journal-title":"Fortschr Neurol Psychiatr"},{"key":"2061_CR10","unstructured":"Deutsche Myasthenie Gesellschaft. Deutsches Myasthenie Register. https:\/\/dmg.online"},{"key":"2061_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0043-118475","volume":"45","author":"M Schroeter","year":"2018","unstructured":"Schroeter\u00a0M, Thayssen\u00a0G, Kaiser\u00a0J (2018) Myasthenie \u2013 Exazerbation und Krise. Akt Neurol 45:271\u2013277","journal-title":"Akt Neurol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02061-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-024-02061-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02061-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T12:03:03Z","timestamp":1720094583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-024-02061-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1007\/s00347-024-02061-1","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"assertion":[{"value":"23 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.B.\u00a0Schroeter und M.\u00a0Schroeter geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}